Study of the correlation between administered activity and radiation committed dose to the thyroid in 131I therapy of Graves' disease

被引:14
作者
Traino, AC
Di Martino, F
Lazzeri, M
Stabin, MG
机构
[1] Spedali Riuniti di S Chiara, Serv Fis Sanitaria, I-56125 Pisa, Italy
[2] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA
关键词
D O I
10.1093/oxfordjournals.rpd.a006531
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Substantial reduction in the thyroid volume (up to 70-80%) after I-131 therapy of Graves' disease has been demonstrated and reported in the literature. Recently a mathematical model of thyroid mass reduction during the first month after therapy has been developed and a new algorithm for the radiation committed dose calculation has been proposed. Reduction of the thyroid mass and the radiation committed dose to the gland depend on a parameter k, defined for each subject. The calculation of k allows the prediction of the activity to administer, depending on the radiation committed dose chosen by the physician. In this paper a method for calculating k is proposed. The calculated values of k are compared to values derived from measurements of the changes in thyroid mass in twenty-six patients treated by I-131 for Graves' disease. The radiation committed dose to the thyroid can be predicted within 21%, and the radioiodine activity to administer to the patient can be predicted within 22% using the calculated values of k. The thyroid volume reduction during the first month after therapy administration cart be also predicted with good accuracy using the calculated values of k. The radiation committed dose and the radioiodine activity to administer were calculated using a new, very simple algorithm. A comparison between the values calculated by this new algorithm and the old, classical Marinelli-Quimby algorithm shows that the new method is more accurate.
引用
收藏
页码:117 / 124
页数:8
相关论文
共 18 条
[1]  
Becker D. V., 1989, NEW ENGL J MED, V311, P454
[2]  
BOCKISCH A, 1993, J NUCL MED, V34, P1632
[3]   Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism [J].
Bogazzi, F ;
Bartalena, L ;
Brogioni, S ;
Scarcello, G ;
Burelli, A ;
Campomori, A ;
Manetti, L ;
Rossi, G ;
Pinchera, A ;
Martino, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (02) :499-503
[4]   Outcome of thyroid function in Graves' patients treated with radioiodine: Role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage [J].
Chiovato, L ;
Fiore, E ;
Vitti, P ;
Rocchi, R ;
Rago, T ;
Dokic, D ;
Latrofa, F ;
Mammoli, C ;
Lippi, F ;
Ceccarelli, C ;
Pinchera, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (01) :40-46
[5]   Thyroid volume measurement in thyrotoxic patients: comparison between ultrasonography and iodine-124 positron emission tomography [J].
Crawford, DC ;
Flower, MA ;
Pratt, BE ;
Hill, C ;
Zweit, J ;
McCready, R ;
Harmer, CL .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1997, 24 (12) :1470-1478
[6]  
Di Martino F, 2000, PHYS MEDICA, V16, P127
[7]   I-131 TREATMENT OF HYPERTHYROIDISM - CURRENT ISSUES [J].
FARRAR, JJ ;
TOFT, AD .
CLINICAL ENDOCRINOLOGY, 1991, 35 (03) :207-212
[8]  
MARINELLI LD, 1948, AM J ROENTGENOL, V59, P260
[9]   Changes in thyroid volume in response to radioactive iodine for Graves hyperthyroidism correlated with activity of thyroid-stimulating antibody and treatment outcome [J].
Murakami, Y ;
Takamatsu, J ;
Sakane, S ;
Kuma, K ;
Ohsawa, N .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (09) :3257-3260
[10]   Influence of compensated radioiodine therapy on thyroid volume and incidence of hypothyroidism in Graves' disease [J].
Nygaard, B ;
Hegedus, L ;
Gervil, M ;
Hjalgrim, H ;
Hansen, BM ;
SoeJensen, P ;
Hansen, JM .
JOURNAL OF INTERNAL MEDICINE, 1995, 238 (06) :491-497